Impact of AI Contouring for GYN Brachytherapy, Limbus Contour V1.8 New Models

Discover the impact of AI contouring for GYN brachytherapy, focusing on the new Limbus Contour v1.8 models. Limbus AI has tackled the challenge of developing commercial AI contours dedicated to the complex and variable techniques of HDR brachytherapy for gynecologic cancer treatment. Variations in applicators, packing, contrast types, needles, and imaging characteristics have previously limited other companies. Through collaboration with clinics across several countries and continents, Limbus AI gradually created models that perform well under diverse conditions, ultimately saving valuable time for patients and clinicians involved in treatment planning.

This webinar features insights from medical physicists and radiation oncologists, including Rhydian Caines, MSc and Mona Chopra, MD from The Clatterbridge Cancer Centre NHS Foundation Trust. Rhydian discusses the journey of implementing Limbus's auto-contouring solutions, covering data sharing, clinical validation, and process impacts, and Mona, shares early blind testing experiences, case studies, and clinical perspectives. Don't miss this opportunity discover the real clinical impacts of these AI models from leading experts in the field.

Limbus Contour v1.8 models are available only in select countries in Europe, APAC, Africa, and Latin America.